Your browser doesn't support javascript.
loading
Assay development for high throughput screening of p21(Waf1/Cip1) protein expression in intact cells using fluorometric microvolume assay technology.
Grand-Perret, T; Cik, M; Arts, J; Vander Borght, A; Ercken, M; Valckx, A; Vermeesen, A; Roevens, R; Janicot, M.
Affiliation
  • Grand-Perret T; Oncology Discovery Research, Johnson & Johnson Pharmaceutical R&D, Beerse, Belgium. tgrandpe@prdbe.jnj.com
Drugs Exp Clin Res ; 30(3): 89-98, 2004.
Article in En | MEDLINE | ID: mdl-15366785
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tumor Cells, Cultured / Technology, Pharmaceutical / Cell Cycle Proteins Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Drugs Exp Clin Res Year: 2004 Document type: Article Affiliation country: Bélgica Country of publication: Suiza
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tumor Cells, Cultured / Technology, Pharmaceutical / Cell Cycle Proteins Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Drugs Exp Clin Res Year: 2004 Document type: Article Affiliation country: Bélgica Country of publication: Suiza